ORBIMED ADVISORS LLC (CIK 1055951) reported 95 SEC Form 4 insider transactions across 19 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell SION (115,844 shares), Sell ELVN (24,846 shares), Sell ELVN (1,477 shares), Sell ELVN (787,024 shares), Sell ELVN (46,776 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 115,844 | $5.3M |
| 2026-06-24 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 24,846 | $1.1M |
| 2026-06-24 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 1,477 | $66,465 |
| 2026-06-24 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 787,024 | $35.7M |
| 2026-06-24 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 46,776 | $2.1M |
| 2026-06-17 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 9,086 | $409,052 |
| 2026-06-17 | Enliven Therapeutics, Inc. (ELVN) | Insider | Sell | 272,322 | $12.3M |
| 2026-06-01 | Q32 Bio Inc. (QTTB) | Director | Buy | 1.2M | $10.0M |
| 2026-06-01 | Q32 Bio Inc. (QTTB) | Director | Buy | 625,000 | $5.0M |
| 2026-05-29 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 101 | $4,493 |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 48,546 | $2.2M |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 59,767 | $2.7M |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 184,639 | $8.5M |
| 2026-04-28 | Traws Pharma, Inc. (TRAW) | Insider | Buy | 597,729 | $998,207 |
| 2026-04-23 | Prelude Therapeutics Inc (PRLD) | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | Prelude Therapeutics Inc (PRLD) | Director | Buy | 1.1M | $5.0M |
| 2026-04-21 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 52,397 | $2.3M |
| 2026-04-21 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 2,948 | $131,245 |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 47,814 | $2.1M |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 235,863 | $10.5M |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 226,906 | $10.3M |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 40,416 | $263,512 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 29,319 | $191,453 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 2,400 | $15,312 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 32,523 | $204,570 |
Source: SEC Form 4 filings · as of 2026-07-02